EUVIMEDEUVIMED entdecken
Crossref

Pulmonary hypertension rapidly leading to mortality in a patient with interstitial pneumonia with autoimmune features

Esma Zenbilli, Kerem Ensarioglu, Tuğçe Şahin Özdemirel, Berna Akıncı Özyürek

Journal of Pulmonology and Intensive Care · 2023

DOI: 10.51271/jopic-0012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pulmonology and Intensive Care, 2023. Verfasst von Esma Zenbilli und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interstitial Pneumonia with Autoimmune Features (IPAF) is a newly defined connective tissue disease (CTD) related pulmonary involvement in 2015 by the European Respiratory Society and American Thoracic Society. It is used to define the subgroup of patients with no known CTD history. In this case report, we present a patient with IPAF diagnosis, who had rapid clinical deterioration after a COVID-19 infection, which was attributed to a newly diagnosed pulmonary hypertension. A 69-year-old male patient with chronic obstructive pulmonary disease (COPD) diagnosis was on the routine follow-up for a duration of five years. He had been diagnosed with type 2 diabetes mellitus and gout, with under constant follow-up for a known cardiovascular arterial disease history. During a routine pulmonary evaluation, the patient had stated a worsening exercise capacity and an increase in coughing. The requested high-resolution computed tomography showed emphysema at the upper lobes and a reticular pattern at the lower lobes, with honeycombing, traction bronchiectasis, and ground-glass findings. After a rheumatology consultation, which excluded the presence of an underlying rheumatological disease, the patient was diagnosed with IPAF. Under immunosuppressive treatment, the patient complained of increased dyspnea at a routine follow-up after a COVID infection in 2021, and antifibrotic treatment was initiated due to the progression of pulmonary fibrosis. During routine follow-up, further limitation in exercise capacity was evident, for which extra-pulmonary involvement was investigated. Pulmonary hypertension (PH) diagnosis was confirmed with vasoreactivity positivity; however, due to both progression in IPAF and concurrent PH, the patient was lost during the follow-up. As seen in this case, despite being stable for years, the addition of another comorbidity may rapidly worsen a patient’s otherwise stable clinical condition. While antifibrotic regimens may be used on a case-by-case basis, their effect on disease progression may not be sufficient to control an already present comorbidity, such as pulmonary hypertension.

Zitieren

APA

Zenbilli, E., Ensarioglu, K., Özdemirel, T. Ş., & Özyürek, B. A. (2023). Pulmonary hypertension rapidly leading to mortality in a patient with interstitial pneumonia with autoimmune features. Journal of Pulmonology and Intensive Care. https://doi.org/10.51271/jopic-0012

Vancouver

Zenbilli E, Ensarioglu K, Özdemirel TŞ, Özyürek BA. Pulmonary hypertension rapidly leading to mortality in a patient with interstitial pneumonia with autoimmune features. Journal of Pulmonology and Intensive Care. 2023. doi:10.51271/jopic-0012

BibTeX
@article{Zenbilli2023,
  author = {Zenbilli, Esma and Ensarioglu, Kerem and Özdemirel, Tuğçe Şahin and Özyürek, Berna Akıncı},
  title = {Pulmonary hypertension rapidly leading to mortality in a patient with interstitial pneumonia with autoimmune features},
  journal = {Journal of Pulmonology and Intensive Care},
  year = {2023},
  doi = {10.51271/jopic-0012}
}
Kostenlos starten →